IO Biotech, Inc.
IOBTDelisted Jun 8, 2026- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001865494
IO Biotech, Inc. was delisted on Jun 8, 2026; its insiders filed their last Form 4 on Jun 6, 2025; 12 institutions reported holding it in 13F filings for Q1 2026, worth $199.0K in total; no superinvestor held it.
Q2 2025 vs. Q1 2025
How the institutions holding IO Biotech, Inc. changed between Q1 2025 and Q2 2025.
All holders in Q2 2025All holders in Q1 2025
| Measure | Q1 2025 | Q2 2025 | Change |
|---|---|---|---|
| Holders | 22 | 26 | +4 |
| Shares | 19.1M | 18.2M | −928.9K (−4.9%) |
| Value | $20.8M | $25.3M | +$4.44M (+21.3%) |
New holders (5)
Institutions that held IO Biotech, Inc. at the end of Q2 2025 but not at the end of Q1 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| GWM Advisors LLC | 24,217 | $33.7K | 0.00% |
| Cubist Systematic Strategies, LLC | 13,096 | $18.2K | 0.00% |
| Two Sigma Securities, LLC | 10,385 | $14.4K | 0.00% |
| Raymond James Financial Inc | 1,000 | $1.39K | 0.00% |
| Citigroup Inc | 314 | $436 | 0.00% |
Sold out (1)
Institutions that held IO Biotech, Inc. at the end of Q1 2025 and filed for Q2 2025 without it.
| Institution | Shares, Q1 2025 | Value, Q1 2025 |
|---|---|---|
| Vontobel Holding Ltd. | 20,029 | $21.8K |